108 related articles for article (PubMed ID: 9422097)
1. Reactivity of antibodies with highly glycosylated MUC1 mucins from colon carcinoma cells and bile.
Sikut R; Sikut A; Zhang K; Baeckström D; Hansson GC
Tumour Biol; 1998; 19 Suppl 1():122-6. PubMed ID: 9422097
[TBL] [Abstract][Full Text] [Related]
2. Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody.
Baeckström D; Nilsson O; Price MR; Lindholm L; Hansson GC
Cancer Res; 1993 Feb; 53(4):755-61. PubMed ID: 7679050
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of a membrane-bound and a secreted mucin-type glycoprotein carrying the carcinoma-associated sialyl-Lea epitope on distinct core proteins.
Baeckström D; Hansson GC; Nilsson O; Johansson C; Gendler SJ; Lindholm L
J Biol Chem; 1991 Nov; 266(32):21537-47. PubMed ID: 1718981
[TBL] [Abstract][Full Text] [Related]
4. Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells.
Medina M; Vélez D; Asenjo JA; Egea G; Real FX; Gil J; Subiza JL
Cancer Res; 1999 Mar; 59(5):1061-70. PubMed ID: 10070964
[TBL] [Abstract][Full Text] [Related]
5. Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells.
Zhang K; Baeckström D; Brevinge H; Hansson GC
J Cell Biochem; 1996 Mar; 60(4):538-49. PubMed ID: 8707893
[TBL] [Abstract][Full Text] [Related]
6. Screening of anti-MUC1 antibodies for reactivity with native (ascites) and recombinant (baculovirus) MUC1 and for blocking MUC1 specific cytotoxic T-lymphocytes.
Ciborowski P; Konitzki WM; Blander JM; Finn OJ
Tumour Biol; 1998; 19 Suppl 1():147-51. PubMed ID: 9422100
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a panel of monoclonal antibodies using GalNAc glycosylated peptides and recombinant MUC1.
Reis CA; Hassan H; Bennett EP; Clausen H
Tumour Biol; 1998; 19 Suppl 1():127-33. PubMed ID: 9422098
[TBL] [Abstract][Full Text] [Related]
8. Carcinoma-associated MUC1 detected by immunoradiometric assays.
Norum LF; Varaas T; Kierulf B; Nustad K
Tumour Biol; 1998; 19 Suppl 1():134-46. PubMed ID: 9422099
[TBL] [Abstract][Full Text] [Related]
9. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996.
Price MR; Rye PD; Petrakou E; Murray A; Brady K; Imai S; Haga S; Kiyozuka Y; Schol D; Meulenbroek MF; Snijdewint FG; von Mensdorff-Pouilly S; Verstraeten RA; Kenemans P; Blockzjil A; Nilsson K; Nilsson O; Reddish M; Suresh MR; Koganty RR; Fortier S; Baronic L; Berg A; Longenecker MB; Hilgers J
Tumour Biol; 1998; 19 Suppl 1():1-20. PubMed ID: 9422084
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell MUC1 and CD43 are glycosylated differently with sialyl-Lewis a and x epitopes and show variable interactions with E-selectin under physiological flow conditions.
Fernandez-Rodriguez J; Dwir O; Alon R; Hansson GC
Glycoconj J; 2001; 18(11-12):925-30. PubMed ID: 12820726
[TBL] [Abstract][Full Text] [Related]
11. Specificity clusters of MUC1-reactive mouse monoclonal antibodies.
Hanisch FG
Tumour Biol; 1998; 19 Suppl 1():111-7. PubMed ID: 9422095
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical characterization of a panel of 56 antibodies with normal human small intestine, colon, and breast tissues.
Cao Y; Karsten U; Hilgers J
Tumour Biol; 1998; 19 Suppl 1():88-99. PubMed ID: 9422093
[TBL] [Abstract][Full Text] [Related]
13. Expression of MUC1 and MUC2 mucins by human tumor cell lines.
Devine PL; Birrell GW; Whitehead RH; Harada H; Xing PX; McKenzie IF
Tumour Biol; 1992; 13(5-6):268-77. PubMed ID: 1283926
[TBL] [Abstract][Full Text] [Related]
14. Epitope characterization of MUC1 antibodies.
Blockzjil A; Nilsson K; Nilsson O
Tumour Biol; 1998; 19 Suppl 1():46-56. PubMed ID: 9422088
[TBL] [Abstract][Full Text] [Related]
15. Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines.
Burdick MD; Harris A; Reid CJ; Iwamura T; Hollingsworth MA
J Biol Chem; 1997 Sep; 272(39):24198-202. PubMed ID: 9305871
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence.
Baldus SE; Hanisch FG; Pütz C; Flucke U; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP
Histol Histopathol; 2002 Jan; 17(1):191-8. PubMed ID: 11813869
[TBL] [Abstract][Full Text] [Related]
17. Epitope mapping of anti-MUC1 mucin protein core monoclonal antibodies.
Petrakou E; Murray A; Price MR
Tumour Biol; 1998; 19 Suppl 1():21-9. PubMed ID: 9422085
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J
Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies against the nonmucin domain of MUC1/episialin.
Hilkens J; Boer M
Tumour Biol; 1998; 19 Suppl 1():67-70. PubMed ID: 9422090
[TBL] [Abstract][Full Text] [Related]
20. A novel monoclonal antibody, H9, directed against the core protein of MUC1 mucin.
Hamada H; Kohno N; Yokoyama A; Kondo K; Yang SZ; Hiwada K; Watanabe K; Miyake M
Oncol Rep; 2000; 7(2):225-32. PubMed ID: 10671662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
